BCYC Q1 2025 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-48.9% YoY

Gross Profit

-$47M-474.0% margin

Operating Income

-$70M-703.7% margin

Net Income

-$61M-608.9% margin

EPS (Diluted)

$-0.88

QoQ Revenue Growth

+169.1%

Cash Flow

Operating Cash Flow

-$87M

Free Cash Flow

-$87M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$884M

Total Liabilities

$144M

Stockholders' Equity

$740M

Cash & Equivalents

$793M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$20M	-48.9%
Gross Profit	-$47M	$20M	-342.2%
Operating Income	-$70M	-$32M	-121.4%
Net Income	-$61M	-$27M	-128.7%